Tag Archives: KEYTRUDA

US FDA approves Merck’s injectable version of blockbuster cancer therapy Keytruda  Reuters FDA OKs New Keytruda Shot for Cancer  The New York Times FDA Approves Subcutaneous Pembrolizumab for Solid Tumors  OncLive Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drug  Endpoints News Merck Wins US Approval of Easier-to-Use Version of Cancer Drug Keytruda  Bloomberg.com Source link

FDA OKs New Keytruda Shot for Cancer  The New York Times FDA Approves Subcutaneous Pembrolizumab for Solid Tumors  OncLive Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drug  Endpoints News Merck Wins US Approval of Easier-to-Use Version of Cancer Drug Keytruda  Bloomberg.com US FDA approves Merck’s injectable version of blockbuster cancer therapy Keytruda  Reuters Source link

Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer  Merck.com FDA OKs New Keytruda Shot for Cancer  The New York Times Pembrolizumab Earns 2 Positive CHMP Opinions in HNSCC, Other EU Indications  OncLive Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial …